author-photo

Philip Campbell

Geelong Football Club
Barwon Health
Geelong Hospital

142

Papers

673

Citations

Citation Trend

Filter By

Papers (107) Sort By

Journal Conference Others

Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥65 years: a two-centre Australian experience.

2021 Internal Medicine Journal
Show All
- Source
- Cite
- Save
Citations (0)
Cereblon pathway biomarkers and immune profiles in patients with myeloma receiving post-ASCT lenalidomide maintenance (LEOPARD)

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Three-Year Follow-up of the Ascend Trial: Acalabrutinib Vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE.

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
"Indium-labelled autologous platelet sequestration studies predict response to splenectomy in immune thrombocytopenia: An Australian experience".

2021 Internal Medicine Journal
Show All
- Source
- Cite
- Save
Citations (0)
Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial.

2021 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Microangiopathic haemolytic anaemia in metastatic renal cell carcinoma: a tale of two distinct pathophysiologies.

2020 Internal Medicine Journal
Show All
- Source
- Cite
- Save
Citations (0)
Acalabrutinib (Acala) versus idelalisib plus rituximab (IdR) or bendamustine plus rituximab (BR) in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): ASCEND final results.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
A Randomized Study of Bortezomib, Cyclophosphamide and Dexamethasone Induction (VCD) Versus VCD and Daratumumab Induction Followed By Daratumumab Maintenance (VCDD) for the Initial Treatment of Transplant-Ineligible Patients with Multiple Myeloma (AMaRC 03-16)

2020 Blood
Show All
- Source
- Cite
- Save
Citations (4)
Measuring The Quality Of Cancer Care In The Barwon South Western Region, Victoria, Australia.

2020 International Journal for Quality in Health Care
Show All
- Source
- Cite
- Save
Citations (0)